Vidalista 2.5 mg is a very low-dose tadalafil medicine used mainly for daily treatment of erectile dysfunction (ED) and sometimes for benign prostatic hyperplasia (BPH). Even at this low dose, it carries important safety warning labels because tadalafil affects blood vessels and blood pressure.

Key warning labels associated with Vidalista 2.5 mg

1. Nitrate interaction warning
It must NOT be used with nitrate medicines (such as nitroglycerin or isosorbide) used for chest pain. This combination can cause a dangerous drop in blood pressure.

2. Heart condition warning
Patients with recent heart attack, stroke, severe heart failure, or unstable angina are advised to avoid it unless specifically cleared by a doctor. Sexual activity itself may also pose a risk in such conditions.

3. Blood pressure warning
Caution is required in people with:

Low blood pressure (hypotension)

Uncontrolled high blood pressure

Use of alpha-blockers or other antihypertensive drugs

4. Kidney and liver impairment warning
Dose adjustment or careful monitoring is needed in patients with kidney or liver disease, as tadalafil is cleared through these organs.

5. Vision and hearing warning
Rare cases of sudden vision or hearing loss have been reported with PDE5 inhibitors. Users are advised to stop the medicine and seek immediate medical help if this occurs.

6. Alcohol and substance warning
Excess alcohol can increase dizziness, low blood pressure, and reduce effectiveness.

Vidalista 2.5 mg carries standard PDE5 inhibitor warnings related to heart disease, blood pressure, nitrates, and organ impairment. Even though it is a low-dose daily medication, these safety labels are important to prevent serious cardiovascular or neurological risks.